Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

946 ARTÍCULOS , VIENDO DEL 16 AL 30

Unveiling tomorrow: Carbonic anhydrase activators and inhibitors pioneering new frontiers in Alzheimer's disease

Mishra KA, Sethi KK.

Arch Pharm (Weinheim). 2025 Jan;358(1):e2400748. doi: 10.1002/ardp.202400748. Epub 2024 Nov 6.

The regulation of miRNAs using curcumin and other polyphenols during the prevention and treatment of Alzheimer's disease

Wang X, Zhang S, Li Y, Zhang Y.

Hum Mol Genet. 2025 Jan 29;34(2):117-127. doi: 10.1093/hmg/ddae154.

Achieving Inclusion in Pharmacological Clinical Trials for Alzheimer's Disease

Molina-Henry D, Raman R.

Curr Top Behav Neurosci. 2025;69:229-242. doi: 10.1007/7854_2024_522.

T-regulatory cells and extracellular vesicles in Alzheimer's disease: New therapeutic concepts and hypotheses

De Sousa RAL, Mendes BF.

Brain Res. 2025 Mar 1;1850:149393. doi: 10.1016/j.brainres.2024.149393. Epub 2024 Dec 11.

The Neuroprotective Effect of Rooibos Herbal Tea Against Alzheimer's Disease: A Review

Chipofya E, Docrat TF, Marnewick JL.

Mol Nutr Food Res. 2025 Jan;69(1):e202400670. doi: 10.1002/mnfr.202400670. Epub 2024 Dec 19.

Progress in the treatment of Alzheimer's disease based on nanosized traditional Chinese medicines

Song D, Zhang J, Hu X, Liu X.

J Mater Chem B. 2025 Jan 29;13(5):1548-1572. doi: 10.1039/d4tb02062f.

The AβA2V paradigm: From molecular insights to therapeutic strategies in Alzheimer's disease and primary tauopathies

Diomede L, Conz A, Mosconi M, Stoilova T, Paloni M, Salvalaglio M, Cagnotto A, Colombo L, Catania M, Di Fede G, Tagliavini F, Salmona M.

Pharmacol Res. 2025 Jan;211:107563. doi: 10.1016/j.phrs.2024.107563. Epub 2024 Dec 27.

Drugs repurposing in the experimental models of Alzheimer's disease

Joodi SA, Ibrahim WW, Khattab MM.

Inflammopharmacology. 2025 Jan;33(1):195-214. doi: 10.1007/s10787-024-01608-7. Epub 2025 Jan 3.

Neuroactive Phytoconstituents of Glycyrrhiza glabra for the Treatment of Alzheimer's Disease

Verma M, Mohd Siddique MU, Singh NK.

Curr Top Med Chem. 2025;25(10):1251-1265. doi: 10.2174/0115680266357793241223100307.

Gut microbiota in Alzheimer's disease: Understanding molecular pathways and potential therapeutic perspectives

Lista S, Munafò A, Caraci F, Imbimbo C, Emanuele E, Minoretti P, Pinto-Fraga J, Merino-País M, Crespo-Escobar P, López-Ortiz S, Monteleone G, Imbimbo BP, Santos-Lozano A.

Ageing Res Rev. 2025 Feb;104:102659. doi: 10.1016/j.arr.2025.102659. Epub 2025 Jan 10.

Cuproptosis and copper as potential mechanisms and intervention targets in Alzheimer's disease

Li Y, Han Y, Shu Q, Kan YK, Wang Z.

Biomed Pharmacother. 2025 Feb;183:117814. doi: 10.1016/j.biopha.2025.117814. Epub 2025 Jan 13.

Mathematical models on Alzheimer's disease and its treatment: A review

Maji M, Khajanchi S.

Phys Life Rev. 2025 Mar;52:207-244. doi: 10.1016/j.plrev.2025.01.004. Epub 2025 Jan 10.

Multi-Targeting Phytochemicals for Alzheimer's Disease

Bhattacharya RS, Singh R, Panghal A, Thakur A, Singh L, Verma RK, Singh C, Goyal M, Kumar J.

Phytother Res. 2025 Mar;39(3):1453-1483. doi: 10.1002/ptr.8435. Epub 2025 Jan 15.

Histone Deacetylation in Alzheimer's Diseases (AD); Hope or Hype

Ateya NH, Al-Taie SF, Jasim SA, Uthirapathy S, Chaudhary K, Rani P, Kundlas M, Naidu KS, Amer NA, Ahmed JK.

Cell Biochem Biophys. 2025 Jun;83(2):1537-1553. doi: 10.1007/s12013-025-01670-0. Epub 2025 Jan 18.

Drug repurposing using artificial intelligence, molecular docking, and hybrid approaches: A comprehensive review in general diseases vs Alzheimer's disease

Zulhafiz NA, Teoh TC, Chin AV, Chang SW.

Comput Methods Programs Biomed. 2025 Apr;261:108604. doi: 10.1016/j.cmpb.2025.108604. Epub 2025 Jan 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias